Modulating the UPS to enhance antioxidant enzyme expression, to control Nrf2 activation, and to improve proteasome function can be benefit metabolic disorders by alleviating ROS-related effects (Figure 8). The gene discussed is NFE2L2; the disease is Other metabolic disease.